., Ltd. (“Park Origin”) amounting to 3,384,520 shares at the par value of THB 100 per share which is an amount equivalent to 25.29 percent of the total number of shares of Park Origin, from the existing
., Ltd. (“Park Origin”) amounting to 3,384,520 shares at the par value of THB 100 per share which is an amount equivalent to 25.29 percent of the total number of shares of Park Origin, from the existing
the capital increase, the Company shall dispose 90,000 preference shares, with the par value of THB 10 per share, equivalent to 47.37 percent of the total shares in Origin Grand, at the offering price
Margin (%) 49.5% 35.5% 13.9% 28.1% 33.3% -5.2% Executive Summary Revenue from Sales and Services • Yggdrazil Group Public Company Limited (“Company”) has total revenue from sales and services equivalent to
. Subscription of 805,264 newly issued ordinary shares of Hero Experience under which there will be the increase in the registered capital of Hero Experience, equivalent to 30 percent of the registered capital of
สัดส่วนกลุ่มอุตสำหกรรมที่กองทุนหลักลงทุน Health Care 27% Biotechnology / Medical 73% Well Global Health Care Equity Fund (WELL) เงินฝำกธนำคำร หมายเหตุ : เป็นข้อมูล ณ วันที่ ......... ทั้งนี้คุณสามารถดู
Limited (“SUTG”), in equivalent to 66 percent of SUTG’s issued and paid-up shares. SUTG is engaging in the business of a construction contractor, provision of service regarding the operation and maintenance
69,358,353.40. The shares increment is registered for paid-up from Baht 784,968,760.00 to Baht 1,280,385,570.00 equivalent to ordinary shares by number of 1,280,385,570 shares in the par value of Baht 1.00 per
23,500,000 ordinary shares (or approximately equivalent to 29.38% of total paid-up capital after the IPO Plan) to the public for the purpose of IPO Plan in TWSE. In addition, the Company will provide not more
23,500,000 ordinary shares (or approximately equivalent to 29.38% of total paid-up capital after the IPO Plan) to the public for the purpose of IPO Plan in TWSE. In addition, the Company will provide not more